Clinical and economic outcomes assessment with myocardial contrast echocardiography Review uri icon

Overview

MeSH Major

  • Cost Savings
  • Echocardiography
  • Heart Diseases

abstract

  • Despite the newness of available myocardial contrast echocardiographic agents, there is a growing body of evidence that demonstrates their clinical and economic value. In general, an overall improvement in image quality is seen with the use of intravenous contrast agents in patients with an initially poor acoustic window. The added value of contrast might be especially important for patients undergoing stress echocardiography. Given a similar diagnostic accuracy, shifting of resources from nuclear to stress contrast echocardiographic imaging could provide tremendous cost savings for the limited financial resources of any European country or North American state.

publication date

  • November 17, 1999

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC1766514

PubMed ID

  • 10534326

Additional Document Info

start page

  • III16

end page

  • 21

volume

  • 82

number

  • SUPPL. 3